…perience of CLL patients treated with reduced doses of IBR in a primary care hospital. Calculate the economic savings derived from this dose reductio…
All extracted institutions
Showing 1,981–2,040 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.
Articles mentioning institutions
11,350 articles · page 581 of 946…ent.Material and Methods The dataset used was obtained from the University of California-Irvine Machine Learning Repository, comprising 589 individuals classified into five groups: blood …
…ty of fruquintinib in adult patients with mCRC treated at three tertiary hospitals.Material and Methods Observational, retrospective, multicentre …
…eases society of America. Clin Infect Dis. 2011;52(4):e56–93.2. European Society for Medical Oncology (ESMO). Management of febrile neutropenia: ESMO clinical practi…
…th nintedanib in patients with pulmonary fibrosing disease in a tertiary hospital.Material and Methods Observational, retrospective, single-centr…
…aterial and Methods A structured search strategy was applied in PubMed to identify phase II/III randomised clinical trials assessing i…
… Methods Single-centre, retrospective observational cohort at a tertiary-level hospital, including all patients with homozygous familial hypercholester…
…g ECMO.Material and Methods Adult ICU patients (>18 years) at a tertiary hospital receiving meropenem 2g q8h(3h-infusion) under ECMO were prospec…
…Methods A retrospective, observational study was conducted at a tertiary hospital between October 2023 and September 2025. All patients receiving…
… with mHSPC receiving full-dose apalutamide and followed in the outpatient oncology pharmacy unit were included if they initially received the 60 mg presentation…
… cancer undergoing treatment from Feb. 2022 to Jan. 2025 in the oncology day hospital.The VTE was assessed using the KRS. For patients with a KRS ≥3,…
…Background and Importance According to the French Society of Clinical Pharmacy, pharmaceutical consultations are structured exchanges between …